Celltrion Archives | Be Korea-savvy
Celltrion to Conduct Additional Phase 1 Trial for Coronavirus Treatment

Celltrion to Conduct Additional Phase 1 Trial for Coronavirus Treatment

SEOUL, Aug. 26 (Korea Bizwire) — Celltrion Inc., a leading pharmaceutical firm in South Korea, said Wednesday that it will conduct an additional phase one clinical trial of its coronavirus treatment on patients. Celltrion’s CT-P59 will be administered to nine COVID-19 patients with mild symptoms to evaluate the safety and efficacy of the antiviral antibody [...]

S. Korea Approves Phase 1 Trials for Celltrion’s COVID-19 Treatment Substance

S. Korea Approves Phase 1 Trials for Celltrion’s COVID-19 Treatment Substance

SEOUL, July 17 (Korea Bizwire) — South Korea approved phase one clinical trials for Celltrion Inc.’s coronavirus antibody treatment substance, the country’s drug safety agency said Friday. The move to test CT-P59 marks the first time that a locally made genetic recombination antibody treatment material has been given the green light to be used on [...]

Celltrion Eyes Exports of Virus Test Kits in July

Celltrion Eyes Exports of Virus Test Kits in July

SEOUL, June 16 (Korea Bizwire) — South Korean biopharmaceutical firm Celltrion Inc. said Tuesday that it will export two kinds of diagnostic kits for the novel coronavirus starting next month. A point-of-care antigen testing (POCT) kit, co-developed by local health care firm BBB, will first be commercialized in countries that lack diagnostic infrastructure, Celltrion said. [...]

Celltrion to Study Efficacy of Remsima on COVID-19 in Britain

Celltrion to Study Efficacy of Remsima on COVID-19 in Britain

SEOUL, June 10 (Korea Bizwire) — An affiliate of South Korean biopharmaceutical firm Celltrion Inc. said Wednesday that it will begin a study on the treatment efficacy of its biosimilar Remsima on the novel coronavirus. Celltrion Healthcare, which handles Celltrion’s overseas business, said the trial study of Remsima, a biosimilar drug to treat autoimmune diseases, [...]

Celltrion’s COVID-19 Treatment Candidate Shows Positive Results in Animal Testing

Celltrion’s COVID-19 Treatment Candidate Shows Positive Results in Animal Testing

SEOUL, June 1 (Korea Bizwire) — South Korean biopharmaceutical firm Celltrion Inc. announced Monday that positive results were shown for its treatment for the novel coronavirus in animal testing. The company said its antiviral antibody treatment showed a 100-fold reduction in the viral load of SARS-CoV-2, the virus known to be causing COVID-19, in an [...]